CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...